At RayBiotech, we have pioneered the development of high quality antibody and protein array technologies. With these, we efficiently analyze the concurrent expression and function of hundreds of proteins involved in inflammation, angiogenesis, apoptosis, cell growth, and signal transduction from a single biological sample. Here, we provide a reliable and high-throughput technology for the screening of novel biomarkers, identification of new drug targets, and determination of key factors for early detection of diseases. Our technologies have the potential to contribute significantly to the realization of the heralded promise of personalized medicine for patients.